Trials / Completed
CompletedNCT03056885
Inflammatory Local Response During OLV: Protective vs Conventional Ventilation Strategy
Does a Protective One Lung Ventilation Strategy Reduce the Inflammatory Cytokine Local Response After Pulmonary Resection?
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- University of Roma La Sapienza · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the local cytokine inflammatory response during one lung ventilation in patients undergoing pulmonary lobectomy or wedge resection. We compare two different ventilation strategies: a conventional strategy with a protective strategy.
Detailed description
One-lung ventilation (OLV) is a ventilation procedure used for pulmonary resection often causing lung injury. International guidelines have recommended for years the use of conventional ventilation (CV) with high tidal volume (VT) (8-10 ml\\kg).A body of recent evidences have shown that conventional ventilation can reduce systemic oxygenation, increase inflammatory products and cause lung tissue damage. In this study we compare the conventional strategy , consisted of Vt 10 mL/kg, with the protective strategy, consisted of Vt 5 mL/kg. Both Vt were based on predicted body weight (PBW). Broncho-alveolar lavages (BAL) are selectively performed in the dependent (ventilated) lung before and at the end of the OLV. The levels of pro-inflammatory (IL-1α, IL-1β, IL-6, IL-8, TNF) and anti-inflammatory (IL-2, IL-4, IL-10, INFγ) cytokines are evaluated. We also evaluate patients clinical outcomes in terms of incidence of postoperative respiratory complications and length of stay.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Conventional One-Lung Ventilation | Vt 10 ml/kg |
| OTHER | Protective One-lung ventilation | Vt 5 ml/kg |
Timeline
- Start date
- 2015-11-02
- Primary completion
- 2015-11-25
- Completion
- 2016-01-15
- First posted
- 2017-02-17
- Last updated
- 2017-02-17
Source: ClinicalTrials.gov record NCT03056885. Inclusion in this directory is not an endorsement.